Involvement of the serotonergic system in orexin-induced behavioral alterations in rats

Regul Pept. 2002 Mar 15;104(1-3):119-23. doi: 10.1016/s0167-0115(01)00355-x.

Abstract

We have demonstrated involvement of the serotonergic system in orexin-induced behavioral responses in rats. Orexin-A and -B (hypocretin-1 and -2) significantly increased total locomotor activity when administered centrally. They also induced behavioral alterations; increasing grooming, face washing and wet dog shaking in rats. Haloperidol inhibited orexin-induced hyperlocomotion and these behavioral alterations. Serotonin antagonists, ritanserin and metergoline, did not attenuate orexin-induced hyperlocomotion but partly inhibited orexin-induced behavioral alterations. These results suggest that the dopaminergic system might be involved in orexin-induced hyperlocomotion, while both the serotonergic system as well as the dopaminergic system might be involved in orexin-induced behavioral responses.

MeSH terms

  • Animals
  • Carrier Proteins / pharmacology*
  • Dopamine / physiology*
  • Dopamine Antagonists / pharmacology
  • Grooming / drug effects
  • Grooming / physiology
  • Haloperidol / pharmacology
  • Injections, Intraventricular / methods
  • Intracellular Signaling Peptides and Proteins*
  • Locomotion / drug effects*
  • Locomotion / physiology
  • Male
  • Metergoline / pharmacology
  • Neuropeptides / pharmacology*
  • Orexins
  • Rats
  • Rats, Wistar
  • Ritanserin / pharmacology
  • Serotonin / physiology*
  • Serotonin Antagonists / pharmacology

Substances

  • Carrier Proteins
  • Dopamine Antagonists
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins
  • Serotonin Antagonists
  • Ritanserin
  • Metergoline
  • Serotonin
  • Haloperidol
  • Dopamine